Quotes of interbank currency market of Ukraine (UAH for $1, in 01.09.2023-30.09.2023)
Source: Open4Business.com.ua and experts.news
Population structure of Ukraine (data from Ukrainian institute of future)
Source: Open4Business.com.ua and experts.news
Number of refugees from Ukraine in selected countries as of 01.11.2023
Source: Open4Business.com.ua and experts.news
Dneprovagonmash, Ukraine’s largest railcar manufacturer, controlled by businessman Sergiy Tigipko’s TAS Financial and Industrial Group, ended January-September 2023 with a net profit of UAH 51.09 million, up 8.3 times compared to the same period in 2022.
According to the company’s interim financial statements published on Wednesday in the NSSMC’s information disclosure system, its net sales revenue decreased by 14.7% to UAH 724.62 million.
In January-September, the company increased its gross profit by 18.7% to UAH 96.9 million, earning UAH 53.5 million in operating profit (4.6 times more).
The report does not disclose the number of railcars produced and sold in the reporting period.
As before, the report mentions the risk of rising prices for components, materials and energy (material costs account for 80-90% of the cost of production) and lower prices for railcars as price risks for the company.
“Ongoing military operations, uncertainty of further developments, including the intensity or potential timing of the cessation of these actions, may significantly affect the economic situation in the country and, accordingly, the activities of Dneprovagonmash,” the report says.
As reported, in the first half of this year, DVM received UAH 57.85 million in net profit against almost UAH 25 million in losses for the same period last year, with net income growing by 17.2% to UAH 578 million.
Thus, in the third quarter of 2023, the company received a UAH 6.76 million loss against a UAH 31.14 million net profit in July-September 2022, with net income falling 2.4 times to UAH 146.61 million.
“Dneprovagonmash is one of Ukraine’s leading freight car design and manufacturing companies. Its annual production capacity is 9 thousand units.
As reported, an extraordinary meeting of shareholders of DVM JSC on July 25 decided to transform it into TAS Dneprovagonmash LLC.
In October of this year, in cooperation with Austrian partners, the company shipped the first lightweight modular freight cars (MultiBOX) intended for use on the EU railways as part of the TransANT innovation project.
In 2022, DVM’s net income increased by 77.3% to UAH 1 billion 108.7 million, with net profit of UAH 48.64 million compared to a loss of UAH 111.3 million a year earlier. At the same time, sales of railcars increased by 35% to 623 units, and production by 21% to 577 units.
TAS Group was founded in 1998 by businessman Tigipko. Its business interests include the financial sector (banking and insurance) and pharmacy, as well as industry, real estate, and venture capital projects.
Last week was a landmark for cytologists in Ukraine, as the II Congress of the Association of Cytopathologists of Ukraine was held at the National Cancer Institute with the support of the National Cancer Institute. This event has become an important platform for the exchange of experience and knowledge between domestic and foreign specialists.
The CSD LAB cytology team also took an active part in the congress. Our colleagues presented three relevant reports that aroused the interest of the audience.
Valentyna Karpachova, a biologist and cytologist of the highest qualification category, shared the results of using an innovative methodology for examining uterine cavity aspirates. This technique allows to improve the accuracy of diagnosis of cervical and endometrial diseases.
Tetiana Yaroshchuk, a laboratory cytologist of the highest category, pathologist, presented a report on the Papanicolaou classification for cytology of the pancreatic-biliary system, which is important for the early diagnosis of pancreatic cancer and other digestive diseases.
Pavlina Botsun, Head of the CSD LAB Cytomorphology Laboratory, spoke about new trends in cervical screening as part of the WHO’s global strategy to eliminate cervical cancer. These trends are aimed at increasing the effectiveness of screening and reducing mortality from this disease.
We are pleased that our colleagues were able to share their knowledge and experience to help improve the quality of cytological diagnostics in domestic medicine.
Benchmark oil prices are little changed on Wednesday morning.
The price of January futures for Brent on the London ICE Futures exchange at 7:02 a.m. is $82.42 per barrel, which is 3 cents lower than at the close of the previous session. On Tuesday, these contracts rose in price by 13 cents to $82.45 per barrel.
Quotes for January futures for WTI in electronic trading on the New York Mercantile Exchange (NYMEX) by this time fell by 1 cent to $77.76 per barrel. At the end of the previous session, they fell by 6 cents to $77.77 per barrel.
Market participants are waiting for the OPEC+ meeting to take place next weekend. Earlier, the Financial Times wrote, citing sources, that the meeting may consider extending the current restrictions on oil production that expire at the end of the year or a sharper reduction in fuel production.
“We think the group has room to increase production cuts, but we believe Saudi Arabia will insist that other countries share the burden,” wrote RBC Capital analyst Helima Croft.
In addition, investors are evaluating signals about changes in energy reserves in the United States. According to the American Petroleum Institute (API), last week, US stocks jumped by almost 9.1 million barrels.
Official data from the Energy Ministry will be published at 17:30 on Wednesday.
Trading activity in the oil market is likely to be lower at the end of the week due to the Thanksgiving holiday in the US.
